Article thumbnail

Effects of Interferon-α/β on HBV Replication Determined by Viral Load

By Yongjun Tian, Wen-ling Chen and Jing-hsiung James Ou

Abstract

Interferons α and β (IFN-α/β) are type I interferons produced by the host to control microbial infections. However, the use of IFN-α to treat hepatitis B virus (HBV) patients generated sustained response to only a minority of patients. By using HBV transgenic mice as a model and by using hydrodynamic injection to introduce HBV DNA into the mouse liver, we studied the effect of IFN-α/β on HBV in vivo. Interestingly, our results indicated that IFN-α/β could have opposite effects on HBV: they suppressed HBV replication when viral load was high and enhanced HBV replication when viral load was low. IFN-α/β apparently suppressed HBV replication via transcriptional and post-transcriptional regulations. In contrast, IFN-α/β enhanced viral replication by inducing the transcription factor HNF3γ and activating STAT3, which together stimulated HBV gene expression and replication. Further studies revealed an important role of IFN-α/β in stimulating viral growth and prolonging viremia when viral load is low. This use of an innate immune response to enhance its replication and persistence may represent a novel strategy that HBV uses to enhance its growth and spread in the early stage of viral infection when the viral level is low

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3145790
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1991). A
  2. (2002). A road map for those who don’t know JAKSTAT. Science 296: 1653–1655. Type I Interferons on
  3. (1991). Characterization of the hepatitis B virus EnhI enhancer and X promoter complex.
  4. (2010). Control of hepatitis B virus at the level of transcription.
  5. (2002). Enhancement of hepatitis B virus replication by its X protein in transgenic mice.
  6. (2010). Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion.
  7. (2007). Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice.
  8. (2011). Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon.
  9. (2000). Highthroughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system.
  10. (2002). Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection.
  11. (2002). Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes.
  12. (2002). Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.
  13. (2004). Interferons, interferon-like cytokines, and their receptors.
  14. (2000). Intrahepatic induction of alpha/ beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.
  15. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.
  16. (2003). Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2.
  17. (2010). Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment.
  18. (1996). Purification and properties of rat liver nuclear proteins that interact with the hepatitis B virus enhancer 1.
  19. (1994). Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3.
  20. (2003). Regulation of hepatitis B virus replication by the ras-mitogen-activated protein kinase signaling pathway.
  21. (2002). Siddiqui A
  22. (2003). Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4.
  23. (2010). The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication.
  24. (2010). The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein.
  25. (2009). The size of the viral inoculum contributes to the outcome of hepatitis B virus infection.
  26. (1990). The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element.
  27. (2010). Toll-like receptorinduced innate immune responses in non-parenchymal liver cells are cell typespecific.